Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (AFF008A)

http://clinicaltrials.gov/ct2/show/N...&sel_rss=mod14

This is a follow-up study to assess safety and clinical activity of continued AFFITOPE® PD01A vaccinations in patients with Parkinson's disease. Patients, who have already participated in AFF008 will be involved and will be receive one boost immunization with AFFITOPE® PD01A. One study site in Vienna (Austria) will be involved.

In addition, up to 8 patients will be offered participation within an untreated control group.

Badboy, this is the follow-up AffiRis study that we've all be referring to over the past two weeks. It's not open for new recruits and, as you posted, the only test site is in Vienna.

It's also invitation only and has no waiting list. "Unless you know somebody"